{"name":"ImaginAb, Inc.","slug":"imaginab-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"⁸⁹Zr-Df-IAB22M2C Infusion","genericName":"⁸⁹Zr-Df-IAB22M2C Infusion","slug":"zr-df-iab22m2c-infusion","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"⁸⁹Zr-Df-IAB22M2C Infusion","genericName":"⁸⁹Zr-Df-IAB22M2C Infusion","slug":"zr-df-iab22m2c-infusion","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNRUlhWHNhVDRPTHNwZVZrUDg5ZDZtbGV3SzF5WVZCSHFNNnc4N3p2dXFmWkxuczJWbERHSUF6OTVEVlItNEIxeUxHbDBCX1drbjEycjA2d3doN3JaaHhFZ1NsckhqOGJlTWRrLXpUc1lpWlhIQkViODBoTjJiUUE5T1NETUd2engxX1RRbnVGOHVyektWbExsSVNMbU1fNGhVQkdtMDFwTUlZMmJYX0FmOFluWFlmZzNUTk13clhtdTEzcThvTkthZXVfanZFNlk3QVFhN3dvR2czNHFzS3RrWEpSRml5b1A4?oc=5","date":"2025-01-31","type":"pipeline","source":"BioPharma APAC","summary":"Telix Pharmaceuticals Completes Acquisition of ImaginAb’s Next-Gen Therapeutic Pipeline and Biologics Platform - BioPharma APAC","headline":"Telix Pharmaceuticals Completes Acquisition of ImaginAb’s Next-Gen Therapeutic Pipeline and Biologics Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPYllJUi1FUlNaYzY2RnJUc3FvVGNEcm81NGh5OXdGRUcxUXdRUkppQ241c1Fzb3h4ZDM3SzF4WEszTkVuakFnaFdRZ2tnUExSeVZCX0ViRUlOTTdmQWdlSkVleTc3Y09PLVZDV3VqbVB1X2piNVpIMG9Qcm5EQzJqTDV6Nk5SMlROYTBwUGRUamIwU2FFY2lkWTd5VEY2c2JveHJ4d19peGREajY4TEl3bVJDcHJuRnNMVi1XV0l3MFBRMnpDaHh6eDBwekdBTmRVSXJGOHBZVy0yWm1mdlJHNnNIU3VZUEZGQzBSTkhoT085b2RMSWtibFNHdklpamxianB4NkNsTC04ZGUydzFR?oc=5","date":"2025-01-22","type":"deal","source":"prnewswire.com","summary":"ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery - prnewswire.com","headline":"ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets d","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPM0dveFJrdEcwejJzLVVtQllpY0xUTVBoMG5xN1ZPQ1JVRkJHV0htNUxWd21IVjRscmt6S3MyNzZSOW9uMWpNejFyM1pLazJ6cUdibE9qc1VLa29rc1Q2bkNMZlc4d2diUml4VkZQRDZ5ZXZBOFM0bkNqeEJFX0I3QjZpaVFFUXdxUjRqaFloNHBGaW5kd1BHU2dqcmp6SkxFYV9JWDNMZUViX0c4ai1ZZjFHamhJVE0xMWc?oc=5","date":"2025-01-13","type":"pipeline","source":"Fierce Biotech","summary":"Telix continues shopping spree with $45M purchase of ImaginAb's preclinical drugs, facility - Fierce Biotech","headline":"Telix continues shopping spree with $45M purchase of ImaginAb's preclinical drugs, facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxQNURjWXBVd2hheWNTV0c1VG1SNldsdFB4NzFjTnBFeDg2TEY0TWRIdmdrcG1RQmhPdzM1OUp5YlY0Uy1kaGxFdFNUelV5dURXcVVzRkl5aE5JQXFIU1hETHpEdjZrYWpWel9vdjBHUF9DVmMyblR5RlpCcnQwU3hKRkNRaktNTk1nSkUzeFdxMW41VVJYbU13ZUw4SlhLREU3RVozTnlJakxnc2QxZUhfM0hmUG1sLXhXbGFoUkdWVkpxbm5YOFVxdEFOd0N0Y25NQ3dBVldabk1CbTdTQ183T3V6R0lERHkzOW9Tc0JnZGVvMkxZSVZQbU9wRXFzLThR?oc=5","date":"2025-01-13","type":"deal","source":"BioPharma APAC","summary":"Telix Pharmaceuticals Acquires ImaginAb’s Biologics Platform and Therapeutics Pipeline to Advance Precision Radiopharmaceuticals - BioPharma APAC","headline":"Telix Pharmaceuticals Acquires ImaginAb’s Biologics Platform and Therapeutics Pipeline to Advance Precision Radiopharmac","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNcGhTMXcxMEpOc0lDeXlBUzVUdWd3eGpaNlM1N0tzR0lmN0duRmJPYjM4V3JBZmFFcGl2eFJhLVF5VHNXTmplQ19IcjlmRjloQTNJNGJOb2pjamVlcUtpWHViRjdEYXhGd3ZqTl9aX3hPVy1DMVJ1X2IzQk5HQkNqTW1vSmd6WmoxRW1aUE9YZVNXMXIydXhzejhDY3NZM0VtMWhSdWxsN19TTkNJQWdaNW5oN2M5RXhDYnJWWm5BRXdGUFFoUkpqWF9Lb1BrUzNteW5NSGpVMzBSSWtxalFCT0VVRTBaQQ?oc=5","date":"2025-01-13","type":"deal","source":"Radiology Business","summary":"Telix Pharmaceuticals to acquire portfolio of imaging-related assets for up to $185M - Radiology Business","headline":"Telix Pharmaceuticals to acquire portfolio of imaging-related assets for up to $185M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE82cjl2dWM0MG9ydVlqbzl1NllWWk02WVpnS2VkVjNnUmJTZV9hUFhVQUFrUU5DMmZkTTVzanE5V0dEZmp5d2VBcjNEZ2pTV3hZcWNv?oc=5","date":"2025-01-12","type":"pipeline","source":"FirstWord Pharma","summary":"Radiopharma space: Lantheus adds Alzheimer's product, Telix targets US - FirstWord Pharma","headline":"Radiopharma space: Lantheus adds Alzheimer's product, Telix targets US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQUDR3WkZSaFUteVRZOXdNSHpfX1F5ZDRucHFUY3hpU1l5dDBqcnJ4MExwOEtUSkNVV1J4TEwyVl9qa3ZDRGFnWEc3Q3Vtakk1dFkyUU5zakhNR05xUGxFQ2FQeXA2Q1hkVXJIMHpaeDExb3BFazhqbldrbzJtWWk1Q2J4UXpMeHh5aHZSM2hOX252TTEtcjJER2M5MDIxd3RGa1dCYW9XV0hBS1k5NkNrZ2x2d0NZM0p6MGtPRkRFb215ZlVENGxKR3hKc3BKZXI4ZGZqcG9UbEgyR1I4Nzh2SE1ycDJpOFE?oc=5","date":"2025-01-12","type":"deal","source":"prnewswire.com","summary":"Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform - prnewswire.com","headline":"Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQQm9ib0tlOUVnUDgyNXkwVmRubE1JbE0tUU03cVdCN0VpbkFUY0JuY2R2clMxNmZOakQzVjdoLVk3LXZiRTMtUXJfVkVEZ3dJN2c2OC04ckxYQWtnRExvSGxwWXhEOGFPcWQ2QjJzazFsT1Ntd0JSMXJvMFBXOVY2UGJ6NjdEeU1QNFVJSHdfczlLZEZFbllRRnUyMHJvdjRtc1VMa3ZVSVRiUGhzM2lvcEp4ejhRSlRNQldHTUFtMTlndG8?oc=5","date":"2025-01-02","type":"pipeline","source":"BioSpectrum Asia","summary":"Businessperson of the year 2024- Dr Christian Behrenbruch (Telix Pharma) - BioSpectrum Asia","headline":"Businessperson of the year 2024- Dr Christian Behrenbruch (Telix Pharma)","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}